A phase III trial of intraepithelial therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission

A phase III trial of intraepithelial therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	571-578
Journal	Journal of Clinical Oncology
Volume	24
Publication status	Published - 2006

Cite this

@article{396840569ad64a00954ef07cfcd0e113,

title = "A phase III trial of intraepithelial therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission",

author = "RHM Verheijen and L.F. Massuger and BB Benigno and AA Epenetos and A. Lopes and JT Soper and J. Markowska and R Vyzula and T Jobling and G Stamp and G Spiegel and D Thurston and T Falke and J. Lambert and MW Seiden",

year = "2006",

language = "English",

volume = "24",

pages = "571--578",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - A phase III trial of intraepithelial therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission

AU - Verheijen, RHM

AU - Massuger, L.F.

AU - Benigno, BB

AU - Epenetos, AA

AU - Lopes, A.

AU - Soper, JT

AU - Markowska, J.

AU - Vyzula, R

AU - Jobling, T

AU - Stamp, G

AU - Spiegel, G

AU - Thurston, D

AU - Falke, T

AU - Lambert, J.

AU - Seiden, MW

PY - 2006

Y1 - 2006

M3 - Article

SN - 0732-183X

VL - 24

SP - 571

EP - 578

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -